Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01196312 · ClinicalTrials.gov registry record · NA
Anxiety Sensitivity Treatment for Heroin Users
A NA study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT01196312 is a NA study that has completed, run by University of Maryland, College Park. The registered enrollment target is 60 participants.
The verdict
NCT01196312, a NA study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatment. ASTH-HR will integrate established treatment modules such as Healthy Relationships, along with interoceptive exposure, affect management, and psycho-education exercises developed for anxiety prevention and treatment programs with standard substance use treatment.
Interventions
- BEHAVIORAL Anxiety sensitivity therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2009-10 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01196312
The ClinicalTrials.gov registry entry for NCT01196312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anxiety sensitivity therapy is the first listed.
NCT01196312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01196312 about?
NCT01196312 is a clinical study titled "Anxiety Sensitivity Treatment for Heroin Users". Anxiety Sensitivity Treatment for Heroin Users is a development project targeting mild and above levels of anxiety sensitivity that will involve the testing of a specialized protocol for improving treatment retention and outcomes for heroin dependent individuals in a residential substance use treatm...
What is the current status of trial NCT01196312?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2009-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01196312?
The interventions under investigation include: Anxiety sensitivity therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01196312?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.